Making the opioid addiction medication buprenorphine more widely available outweighs the risk the drug will be diverted, addiction experts tell NPR. President Trump is expected to sign a bill that would increase access to the medication.
Researchers at New York University are studying whether providing the opioid-addiction medicine extended-release naltrexone (Vivitrol) to individuals when they leave jail reduces their risk of relapse and overdose.
Some insurance companies are restricting patients’ access to pain medicines with a lower risk of dependence or addiction, while making it easier to get generic opioid drugs, The New York Times reports.
Authorities planning for natural disasters such as hurricanes must prepare for its effect on people struggling with drugs or alcohol, experts tell the Associated Press. The stress of hurricanes leads to an increased danger of relapse and overdose.